Stability-Engineered Peptide for Durable Cartilage Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for cartilage regeneration, such as surgical procedures and cell-based therapies, often result in low durability and insufficient regeneration into cartilage tissue, with limitations in cell treatment and potential complications like fibrocartilage formation and vascular invasion.
Innovation Solution
A peptide with an amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 2, engineered for enhanced stability and specificity, is used to induce the production of glycosaminoglycan, collagen, and other cartilage components, promoting effective cartilage regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If surgical procedures such as artificial joints or microfracture are performed, then cartilage damage can be treated, but scars are left due to incisions and regeneration into fibrocartilage with low durability occurs
Solution Approach 1:
The patent extracts and utilizes specific growth factors (FGF-2, BMP-2, TGF-β1) that naturally promote cartilage regeneration, separating their therapeutic effect from the harmful surgical intervention effects. By administering these growth factors through injection or implantation, the treatment achieves cartilage regeneration without the need for invasive surgical procedures that cause scarring and fibrocartilage formation.
Solution Approach 2:
The patent introduces growth factors as intermediary substances that mediate between the treatment goal (cartilage regeneration) and the patient's body. These growth factors act as biological mediators that stimulate endogenous cartilage repair mechanisms, avoiding direct surgical contact with the damaged area and thus preventing scarring and fibrocartilage formation while still achieving effective treatment.
2Ease of operation
If intra-articular injectable solutions or hydrogel compositions are used, then surgical procedure is simple and therapeutic effects are quick, but only temporary pain relief is provided and regeneration into cartilage tissue is insufficient
Solution Approach 1:
The patent combines multiple growth factors (FGF-2, BMP-2, TGF-β1) in specific ratios within a delivery system to create a composite therapeutic composition. This composite approach synergistically enhances cartilage regeneration capability while maintaining the simplicity of injection administration. The combination of different growth factors addresses the limitation of single-factor treatments by providing comprehensive stimulation of cartilage repair processes.
Solution Approach 2:
The patent optimizes parameters such as the concentration ratios of different growth factors, the timing of administration, and the delivery method to maximize cartilage regeneration efficacy. By carefully controlling these parameters, the treatment achieves effective cartilage tissue regeneration while maintaining the advantage of simple injection procedure and quick therapeutic onset.
3Reliability
If cell-based therapy using autologous chondrocytes or stem cells is performed, then cartilage tissue regeneration can be induced, but limitations exist in cell collection and culture, and issues such as cell dedifferentiation, low differentiation rate, and vascular invasion with apoptosis occur
Solution Approach 1:
The patent extracts and utilizes specific growth factors that naturally regulate cartilage cell behavior and differentiation. By administering these growth factors externally, the treatment bypasses the complex cell collection, culture, and manipulation processes required in cell-based therapies. This approach achieves cartilage regeneration through biochemical stimulation rather than cellular intervention, eliminating issues of cell dedifferentiation, low differentiation rates, and vascular invasion.
Solution Approach 2:
The patent introduces growth factors as intermediary substances that mediate cartilage regeneration without requiring direct cellular manipulation. These growth factors serve as biological messengers that stimulate endogenous repair mechanisms, avoiding the need for cell collection, culture, and transplantation procedures. This intermediary approach simplifies the treatment process while maintaining effective cartilage regeneration and avoiding cell-related complications.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present application relates to a peptide having a cartilage regeneration effect, and uses thereof, and provides a peptide including an amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 2, a composition for cartilage regeneration, including the peptide, and a pharmaceutical composition for preventing or treating a cartilage disease, including the composition for cartilage regeneration as an active ingredient.